Headache and symptoms of temporomandibular disorder: An epidemiological study: Research submission

Headache

Volumn 50, Issue 2, 2010, Pages 231-241

  Gonçalves, Daniela A G ^a   Bigal, Marcelo E ^b,c   Jales, Luciana C F ^d   Camparis, Cinara M ^a   Speciali, José G ^e  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d INBIO Instituto de Neuropsicologia e Biofeedback   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epidemiology; Migraine; Prevalence; Primary headaches; Temporomandibular joint

Indexed keywords

ADULT; ARTICLE; CHRONIC DAILY HEADACHE; CHRONIC DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FACE PAIN; FEMALE; HEADACHE; HUMAN; JAW DISEASE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PREVALENCE; PRIMARY HEADACHE; PRIORITY JOURNAL; SYMPTOM; TEMPOROMANDIBULAR JOINT DISORDER; TENSION HEADACHE;

ADULT; AGED; CAUSALITY; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEADACHE DISORDERS; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; PREVALENCE; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS; TENSION-TYPE HEADACHE; YOUNG ADULT;

EID: 75849140533     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01511.x     Document Type: Article

References (52)

1. Cady R, Schreiber C, Farmer K, Sheftell F. Primary headaches: A convergence hypothesis. Headache. 2002 42: 204 216.
2. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia. 2004 24 (Suppl. 1 8 160.
3. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 68: 343 349.
4. Laskin D, Greenfield W, Gale E, eds. The President's Conference on the Examination, Diagnosis and Management of Temporomandibular Disorders. Chicago, IL: American Dental Association 1983.
5. De Leeuw R. Orofacial Pain: Guidelines for Assessment, Diagnoses and Management. Hanover Park, IL: Quintessence Publishing Co, Inc 2008.
6. Drangsholt M, LeResche L. Temporomandibular disorder pain. In: Crombie IK, Croft PR, Linton SJ, LeResche L, Von Korff M, eds. Epidemiology of Pain. Seattle, WA: IASP Press 1999: 203 233.
7. McNeill C. Management of temporomandibular disorders: Concepts and controversies. J Prosthet Dent. 1997 77: 510 522.
8. Salonen L, Hellden L, Carlsson G. Prevalence of signs and symptoms of dysfunction in the masticatory system: An epidemiologic study in an adult Swedish population. J Craniomandib Disord. 1990 4: 241 250.
9. Dando WE, Branch MA, Maye JP. Headache disability in orofacial pain patients. Headache. 2006 46: 322 326.
10. Ballegaard V, Thede-Schmidt-Hansen P, Svensson P, Jensen R. Are headache and temporomandibular disorders related? A blinded study. Cephalalgia. 2008 28: 832 841.
11. Graff-Radford SB. Temporomandibular disorders and headache. Dent Clin North Am. 2007 51: 129 144.
12. Glaros AG, Urban D, Locke J. Headache and temporomandibular disorders: Evidence for diagnostic and behavioural overlap. Cephalalgia. 2007 27: 542 549.
13. De Kanter RJAM, Truin GJ, Burgersdijk RCW, Battistuzzi PGFCM, Kalsbeek H, Käyser AF. Prevalence in the Dutch adult population and a meta-analysis of signs and symptoms of temporomandibular disorders. J Dent Res. 1993 72: 1509 1518.
14. Gesch D, Bernhardt O, Alte D, et al. Prevalence of signs and symptoms of temporomandibular disorders in a urban and rural German population: Results of a population-based study of health in Pomerania. Quintessence Int. 2004 35: 143 150. (Pubitemid 38184092)
15. Lipton RB, Bigal ME. Migraine: Epidemiology, impact and risk factors for progression. Headache. 2005 45 (Suppl. 1 S3 S13.
16. Naito M, Yuasa H, Nomura Y, Nakayama T, Hamajima N, Hanada N. Oral health status and health-related quality of life: A systematic review. J Oral Sci. 2006 48: 1 7.
17. Okeson JP. Dor Orofacial-Guia para Avaliação, Diagnóstico e Tratamento. São Paulo: Quintessence Editora Ltda 1998.
18. Kemper JT Jr., Okeson JP. Craniomandibular disorders and headaches. J Prosthet Dent. 1983 49: 702 705.
19. Ciancaglini R, Radaelli G. The relationship between headache and symptoms of temporomandibular disorder in the general population. J Dent. 2001 29: 93 98.
20. Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology. 1994 44: S4 5.
21. Gonçalves DAG, Speciali JG, Jales LCF, Camparis CM, Bigal ME. Temporomandibular Symptoms, Migraine and Chronic Daily Headaches in the Population. Neurology. In press.
22. Demographic Census 2000. Instituto Brasileiro de Geografia e Estatística (IBGE). IBGE Cities. 2000. Available at: http://www.ibge.gov. br
23. Lipton RB, Katz MJ, Kuslansky G, et al. Screening for dementia by telephone using the memory impairment screen. J Am Geriatr Soc. 2003 51: 1382 1390.
24. Henry P, Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology. 2002 59: 232 237.
25. Lipton RB, Goadsby P, Silberstein SD. Classification and epidemiology of headache. Clin Cornerstone. 1999 1: 1 10.
26. Queiroz LP, Barea LM, Blank N. An epidemiological study of headache in Florianopolis, Brazil. Cephalalgia. 2006 26: 122 127.
27. Rasmussen BK. Epidemiology of headache. Cephalalgia. 1995 15: 45 68.
28. Silberstein SD, Lipton RB. Epidemiology of migraine. Neuroepidemiology. 1993 12: 179 194.
29. Wang SJ. Epidemiology of migraine and other types of headache in Asia. Curr Neurol Neurosci Rep. 2003 3: 104 108.
30. Campos JADB, DAG G Camparis CM, Speciali JG. Reliability of a questionnaire for temporomandibular disorders severity. Braz J Phys Ther. 2009 13: 38 43.
31. Nunnally JC, Bernstein IH. Psychometric Theory, 3rd edn. New York: WCB/McGraw-Hill 1994.
32. Streiner D, Norman G. Health Measurement Scales. A Practical Guide to Their Development and Use. Oxford: Oxford University Press 1995.
33. Light RJ. Measures of response agreement for qualitative data: Some generalizations and alternatives. Psychol Bull. 1971 76: 365 377.
34. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 33: 159 174.
35. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology. 1996 47: 871 875.
36. Carlsson GE, Le Resche L. Epidemiology of temporomandibular disorders. In: Sessle BJ, Bryant PS, Dionne RA, eds. Progress in Pain Research and Management. Seattle, WA: IASP Press 1995.
37. Glass EG, McGlynn FD, Glaros AG, Melton K, Romans K. Prevalence of temporomandibular disorders symptoms in a major metropolitan area. Cranio. 1993 11: 217 220.
38. Locker D, Slade G. Prevalence of symptoms associated with temporomandibular disorders in a Canadian population. Community Dent Oral Epidemiol. 1988 16: 310 316.
39. Morillo LE, Alarcon F, Aranaga N, et al. Prevalence of migraine in Latin America. Headache. 2005 45: 106 117.
40. Lipton RB, Bigal ME. Epidemiology of migraine in Latin America: An editorial. Headache. 2005 45: 103 104.
41. Mitrirattanakul S, Merrill RL. Headache impact in patients with orofacial Pain. JADA. 2006 137: 1267 1274.
42. Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain. 1991 46: 125 132.
43. Quinn JH, Bazan NG. Identification of prostaglandin E2 and leukotrien B4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg. 1990 48: 968 971.
44. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 85: 135 141.
45. Takahashi T, Nagai H, Seki H, Fukuda M. Relationship between joint effusion, joint pain, and protein levels in joint lavage fluid of patients with internal derangement and osteoarthritis of the temporomandibular joint. J Oral Maxillofac Surg. 1999 57: 1187 1193.
46. Fu K, Ma X, Zhang Z, Pang X, Chen W. Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain. 1995 9: 131 137.
47. Shaefr DM, Assael L, White LB, Rossomando EF. Tumor necrosis factor as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg. 1994 52: 786 791.
48. Kopp S. The influence of neuropeptides, serotonin, and interleukin 1β on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg. 1998 56: 189 191.
49. Holmlund A, Ekblom A, Hansson P, Lind J, Lundeberg T, Theodorsson E. Concentrations of neuropeptides substance P, Neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. Int J Oral Maxillofac Surg. 1991 20: 228 231.
50. Henry CH, Wolford LM. Substance P and mast cells: Preliminary histologic analysis of the human temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 92: 384 389.
51. Merrill RL. Central mechanisms of orofacial Pain. Dent Clin North Am. 2007 51: 45 59.
52. Feine JS, Lavigne GJ. The challenge of measuring the efficacy of treatment of chronic trigeminal myofascial Pain. In: Stohler CS. Carlson DS, ed. Biological and Psychological Aspects of Orofacial Pain. Ann Arbor, MI: Needham Press 1994: 113 132.